ABSTRACT
INTRODUCTION
Chronic low-grade inflammation is involved in the pathogenesis of obesity-related type-2-diabetes and its complications [1] . Macrophages (Mϕ) are key cellular mediators in diabetesrelated inflammation [2] and in response to different stimuli e.g. cytokines are polarized into classically activated (M1) or alternatively activated (M2) cells [3] .
The inflammatory M1 sub-type is activated by IFN-γ and bacterial lipopolysaccharide (LPS) and is characterised by the production of proinflammatory cytokines e.g. IL-1, IL-6 and TNF-α. In contrast, the M2 macrophages are activated by IL-4 and IL-13 and have a major role in immune regulation and tissue repair [4] . M2 macrophages produce cytokines and cell-surface receptors such as IL-10, IL-1 receptor antagonist (IL-1Ra) and Dectin-1, and down-regulate inflammatory processes associated with the M1 phenotype [5] . It is now understood that an imbalance in population of M1 and M2 and a predominance of M1 macrophages is a contributing factor to dysregulation of glucose metabolism in adipose tissue and leads to insulin resistance [6] . In line with this, studies have found that adipose tissue macrophages adopt an M1-like phenotype and produce large amounts of pro-inflammatory cytokines [4] .A recent study also found that M2 macrophage polarization was associated with improved insulin resistance in diabetic mice [7] .
Trigonella foenum graecum (Tfg) seeds are used in traditional Indian, Chinese and Middle-Eastern medicine for managing conditions including diabetes [8] , metabolic disorder [9] and cancer [10] . More recently, Tfg seeds have been shown to decrease the release of proinflammatory cytokines such as TNF-α and Interleukin-1β in tissues of diabetic mice [11] .
Neelakantan et al., conducted a meta-analysis on the effects of Tfg seeds on glycaemic control and found a strong association between Tfg intake and hypoglycaemic effect in diabetic patients [12] . In line with that, a saponin-rich water soluble extract of Tfg; Fenfuro™ was recently patented in the US as an antidiabetic agent [13] . Taken together, the literature suggests a role for Tfg seeds in modulating diabetes and related inflammation.
In this study, we aimed to investigate the role of a methanolic extract of Tfg (FME) in regulating markers of M1 and M2 macrophages using an in vitro THP-1 Mϕ cell model.
MATERIALS AND METHODS:
Cell culture: Human promyelocytic cells (THP-1) were cultured in RPMI 1640 (Gibco, UK) supplemented with 10% heat inactivated Foetal Calf Serum; FCS (Labtech International), 1% sodium pyruvate, 1% non-essential amino acids and 1% penicillin (100 IU/ml), streptomycin (100μg/ml) (Gibco, UK). For in vitro differentiation into macrophages, THP-1 monocytes (6 x 10 5 cells/ml) were treated with 8nM phorbol-myristate-acetate; PMA (Sigma) for 48hours then maintained in fresh media without PMA for an additional 48hours before all experiments. In order to achieve a diabetes-related pro-inflammatory phenotype in THP-1 macrophages, cells were treated with 500μg/ml of glycated-BSA (Sigma, UK). HEK293T (ATCC, Middlesex, UK) epithelial cells were grown in complete Dulbecco's Modified Eagle Medium (DMEM), 100U/ml penicillin/100μg/ml streptomycin mix and 4mM L-glutamine (Gibco, UK).
Cell viability assay: Cells were cultured in a 96-well micro-titre plate for 48 hours. Varying concentrations of the FME was incubated with the cells for 24 hours and cell viability was determined using Cell Titer-Blue® (Promega) according to manufacturer's guidelines.
Extract preparation: 40g of Tfg seeds were ground to fine powder and transferred into 100ml of 100% Methanol for incubation in a rotary mixer overnight at 25°C. The solvent fraction was recovered by centrifugation (6000g for 15mins) and the methanol evaporated in vacuo using a rotary evaporator (Bibby RE100, Staffordshire, UK). The residue was further subjected to N 2 to obtain a dry residue. The residue (extract) was dissolved in dimethyl sulfoxide (DMSO) and reconstituted in culture media, filtered through a 0.22µm PVDF filter and stored at -20°C. For experiments, the extract was thawed and reconstituted in fresh media at the respective concentrations before adding to cells.
Quantification of Cytokines using ELISA: TNF-α, IL-6 and IL-1β ELISA kits were obtained from R & D systems (Abingdon, Oxford) and the assay undertaken using protocols outlined by manufacturer.
Quantitative reverse transcription-PCR (qRT-PCR):
Total RNA was extracted from cell pellets using TRIzol ® reagent (Life technologies). RNA was converted to cDNA using a High NF-kB reporter assay: HEK293T cells were grown in a 24-well plate to a confluence of 60-80%. Cells were transfected with 50ng of NF-κB plasmid DNA and 5ng of the Renilla luciferase reporter DNA (Pr6tk; Promega, Southampton, UK) diluted in Opti-MEM® I Reduced-Serum Medium (Invitrogen Ltd, Paisley, UK) using Lipofectamine® transfection reagent (Invitrogen Ltd, Paisley, UK) for 4hours. The media was replaced with fresh media for another 20hours before experiments.
Statistical analysis: all data are presented as the mean + standard deviation. One-way analysis of Variance (ANOVA) was conducted for within group comparisons. The statistical package, Graphpad Prism 5 was used for all statistical analyses. Statistical significance is represented as: * (P-value <0.05); ** (P<0.01); *** (P<0.001). Error bars represent standard deviation of at least three replicates.
RESULTS
The effect of FME on THP-1 Mϕ cell viability. To determine the cytotoxic effect of FME on THP-1 Mϕ, the cells were exposed to a range of concentrations (30-460μg/ml) for 24 hours and then the viability of the cells was assessed. At the concentration of 120μg/ml and above FME significantly reduced cell viability compared to untreated cells (Figure 1 Using non-cytotoxic concentrations of FME, the effect of a range of concentrations 1-50μg/ml FME on gBSA-induced TNF-α release was studied in order to determine the optimal and range of bioactive concentrations. In the absence of gBSA, there was no significant increase in TNF-α secretion compared to the control and VC. All concentrations tested (1-50μg/ml) significantly reduced TNF-α secretion in the cells (Figure 2 ). The most potent concentration was 25μg/ml FME, reducing g-BSA induced TNF-α secretion (1008.429+ 99.5pg/ml vs. 532.1+ 94.2pg/ml). There was no significant difference in TNF-α levels in the treatment groups. Effect of FME on gBSA-induced TNF-α release in THP-1 Mϕ cells. Cells were pre-treated with 1-50μg/ml FME for 1 hour and then the cells were treated with 500μg/ml gBSA for 6 hours. The level of TNF-α secretion was analysed in the cell-free media using ELISA. The difference between all treatment groups was determined by One-way ANOVA with Tukey's post hoc test. It has been previously demonstrated that THP-1 macrophages express a number of M1(proinflammatory) cytokines such as TNF-α, IL-1β and IL-6 upon stimulation of by proinflammatory stimuli such as bacterial LPS and Interferon-γ (IFN-γ) [14] . Upon activation, M1 macrophages are characterised by the ability to secrete high levels of TNF-α, IL1-β and IL-6 cytokines [15] . Having demonstrated the effect of FME on TNF-α secretion in the presence of gBSA (figure 2), we further investigated the role of FME in regulating the secretory pattern of a panel of M1 cytokines within an inflammatory milieu at an early and later time point. At a concentration of 29μg/ml, we found that FME was able to significantly reduce gBSA induced levels of TNF-α ( figure 3), IL-1β (figure 4 ) and IL-6 (figure 5) at 6 and 24hours. Figure 3 . Effect of FME on gBSA-induced TNF-α release in THP-1 Mϕ cells. Cells were pre-treated with 29μg/ml FME for 1 hour and then the cells were treated with 500μg/ml gBSA for a) 6 hours and b) 24 hours. The level of TNF-α secretion was analysed in the cellfree media using ELISA. The difference between treatment groups was determined by Oneway ANOVA with Tukey's post hoc test. Figure 4 . Effect of FME on gBSA-induced IL-1β release in THP-1 Mϕ cells. Cells were pretreated with 29μg/ml FME for 1 hour and then the cells were treated with 500μg/ml gBSA for a) 6 hours and b) 24 hours. The level of IL-1β secretion was analysed in the cell-free media using ELISA. The difference between treatment groups was determined by One-way ANOVA with Tukey's multiple comparison post hoc test. Figure 5 . Effect of FME on gBSA-induced IL-6 release in THP-1 Mϕ cells. Cells were pretreated with 29μg/ml FME for 1 hour and then the cells were treated with 500μg/ml gBSA for a) 6 hours and b) 24 hours. The level of IL-6 secretion was analysed in the cell-free media using ELISA. The difference between treatment groups was determined by One-way ANOVA with Tukey's multiple comparison post hoc test.
The effect of FME on M2 markers in THP-1 macrophages After demonstrating that FME reduces the secretion of M1 cytokines (figure 3-5), we further investigated whether FME up-regulates the expression of M2 markers and can favour an M2 phenotype in the presence of pro-inflammatory gBSA. THP-1 Mϕ cells were pre-treated with FME and then stimulated with gBSA and the expression of M2 genes was analysed using qRT-PCR. There was a significant increase in the gene-expression of IL-10 and IL-1Ra (figure 6a & 6b) in cells treated with gBSA alone and a combination of FME and gBSA, however, there was no significant difference between gBSA and FME-gBSA. Dectin-1 demonstrated a different expression pattern; in the presence of FME-gBSA, there was a significant increase in Dectin-1 expression at mRNA level (figure 6c).
* a b * * Figure 6 . Effect of FME on M2 markers: IL-10, IL-1Ra and Dectin-1 expression in THP-1 Mϕ cells. Cells were pre-treated with 29μg/ml FME for 1 hour and then the cells were treated with500μg/ml gBSA for 24 hours. The RNA from the cell pellets was collected and the expression of M2 makers a) IL-10, b) IL-1Ra, and c) Dectin-1 was analysed using qRT-PCR. The difference between treatment groups was determined by One-way ANOVA with Tukey's multiple comparison post hoc test. NS: not significant. FME significantly reduces TNF-alpha induced NF-kB reporter activity. To determine the mechanism through which the observed effects FME may be mediated, NF-κB gene reporter assay was carried out. Due to the fact that FME reduced TNF-α secretion (fig 2-3) and TNF-α is a known target gene of NF-kB [16] , the effect of FME on NF-kB activity was explored as a potential target for the anti-inflammatory activity of the extract. Many nutraceutical agents are known to exert anti-inflammatory effects through inhibition of NF-kB signalling [17] . In the presence of the TNF-α, there was a significant increase in NFkB reporter activity which was significantly reduced by pre-treatment with FME ( figure 7) . Figure 7 . FME significantly attenuates TNF-alpha stimulated NF-kB activity. HEK-293T cells were co-transfected with NF-kB and Renilla control plasmids for 24hr. The cells were then pre-treated with FME for 1hour. The cells were then stimulated with 10ng/ml TNFalpha. After 24hours post-stimulation, the cells were lysed and gene-reporter activity was analysed using the dual-glo luciferase assay.
DISCUSSION
The role of macrophage polarisation in obesity-linked metabolic disorders such Type-2-diabetes is currently an area that is being extensively explored. The state of chronic lowgrade inflammation as found in obesity can lead to polarization of macrophages from an immune-regulatory M2 to a proinflammatory M1 phenotype [18] . In this study, the role of a methanolic extract of Tfg seeds on macrophage polarization was explored using the human THP-1 macrophage cells. Previous studies have demonstrated that THP-1 macrophages can be polarized into M1 and subtypes of M2 macrophages (M2a and M2c) in vitro [19] and hence was an appropriate model for a study whose primary aim was the regulation of polarization of these immune cells. For instance, in a recent paper, ** Chanput and colleagues explored the polarizing ability of LPS and food compounds such as vitamin D3 and Lentinan in THP-1 macrophages [14] . Although their study found that the food components (Vitamin D3 and Lentinan) had no effect on macrophage polarization, in contrast another paper by Gao et al. reported an M2 phenotype switch in macrophages mediated through release of IL-4 and/or IL-13 following treatment with Curcumin, a widely used food product [20] .
Tfg seeds have been associated with many beneficial effects including antidiabetic, antibacterial, hypocholesterolaemic, anti-inflammatory, anticarcinogenic and hepatoprotective (see review [21] ). We hypothesised that the reported clinical effects of Tfg may be in part attributable to the role of its bioactive flavonoid compounds in attenuating diabetes-related inflammatory processes such as M1 macrophage polarization. In our study we demonstrated that FME significantly reduced gBSA induced secretion of TNF-α, IL-1β and IL-6 by THP-1 macrophages.
Chemical analysis of a hydromethanolic extract of Tfg seeds by Benayad et al., found that the main compounds present were flavonoid glycosides; mainly, apigenin and luteolin glycosides [22] . In concordance with their study, we found that chemical analysis of FME exhibited a similar profile of chemical compounds (data unpublished).
Along with a reduction in M1 cytokines, FME also induced a significant upregulation in the gene expression of an M2 marker; Dectin-1, in the presence of gBSA ( fig. 6 ). There was no difference in IL-10 and IL-1Ra expression compared to the gBSA treatment.
Although inconclusive, our results suggest that FME has the potential to induce a shift towards an M2 phenotype that is characterised by a high Dectin-1 and low IL-10 and IL-1Ra expression. Dectin-1 is a marker that is associated with the M2b subtype of macrophages [23] . Consequently, we propose that other M2b signature markers such as MR and SIGNR3 should be studied to confirm if FME can specifically induce M2b-like phenotype.
Our work also revealed that FME attenuates TNF-α induced NF-κB gene reporter activity. NF-κB plays a central role in the signalling of gBSA (an advanced glycation end product; AGE) [24] and M1 macrophage polarization [25] . Upon binding of AGEs to the receptor for AGE (RAGE), the transcription factor NF-kB is activated, initiating a cellular signalling cascade that results in the production of proinflammatory cytokines such as TNF-α, and IL-1 and IL-6 [26] . The ability of FME to reduce NF-κB activity in the presence of a proinflammatory cytokine (TNF-α) suggests that FME may exert Mϕ polarization through modulating the activity of cellular and transcription factors.
There are a number of other molecular and cellular mechanisms that play a major role in Mϕ polarization. This study only explored a select group of cytokines, cellular receptors and transcription factor involved in this process. Other major molecular mechanisms involved in M1-M2 switch include Nod-like receptors [27] , cytokine signal inhibitors (suppressor of cytokine signalling; SOCS [28] ) and transcription factors such as Peroxisome ProliferatorActivated Receptors (PPARs), Activated Protein-1 (AP-1), Glucocorticoid Receptors, IFN regulatory factors (IRFs), Signal Transducers and Activators of Transcription (STATs) and Krüppel-Like Factors (KLFs) (see review [25] ). Due to the regulatory role of transcription factors in M1-M2 polarization in macrophages and disease, the effect of FME on these transcription factors should be explored.
Conclusion:
The current work has demonstrated that the methanolic extract of Tfg seeds exert potent anti-inflammatory effects and can modulate the release and expression of M1 and M2 markers in a human in vitro macrophage model. These effects appear to be mediated through the regulation of the transcription factor NF-kB, however, further work needs to be carried out to confirm the exact mechanisms through which these effects are mediated and whether these effects would also be observed in vivo.
